The Amsterdam-based company recently received IVDR certification for other tests including one for phenylketonuria.

In a report released today, Bose George from KBW maintained a Buy rating on Dynex Capital (DX – Research Report), with a price target of ...

The awards, by airlineratings.com, are 'centred on passenger comfort, feedback, and product consistency across an airline's ...

BTIG raised the firm’s price target on Dynex Capital (DX) to $16 from $15 and keeps a Buy rating on the shares. The firm’s price target hike ...

Exact Sciences has a multipronged approach to cancer testing. Current products are Cologuard, its flagship stool-based screening test for colorectal cancer, or CRC, and Oncotype DX, its tissue-based ...

UPL Corp., a provider of comprehensive and sustainable agricultural solutions, announces U.S. Environmental Protection Agency ...

Dynex Capital, Inc. (NYSE:DX – Get Free Report) has earned a consensus rating of “Moderate Buy” from the five brokerages that ...

Ares Credit funds served as the administrative agent on the incremental debt financing, which is intended to support Tempus' acquisition of Ambry Genetics.

Real Madrid are set to host Manchester City in the second leg of their UEFA Champions League knockout playoff battle on ...

Ambrosia Biosciences Inc., a drug-discovery company launched last year, has added Jason Haddock, a former executive with ArcherDX Inc. and Array BioPharma Inc., to its board of directors.